Skip to ContentSkip to Navigation
How to find us E.A.M. Festen

Publications

A combination of fecal calprotectin and human beta-defensin 2 facilitates diagnosis and monitoring of inflammatory bowel disease

Biomarkers reflecting extracellular matrix turnover and inflammation can be used to monitor disease activity and treatment response in patients with Crohn's disease undergoing infliximab induction therapy

CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE

CIGARETTE SMOKE INCREASES RISK FOR COLORECTAL NEOPLASIA IN INFLAMMATORY BOWEL DISEASE

Cigarette smoke increases risk for colorectal neoplasia in inflammatory bowel disease

Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients

Donor genetic variants as risk factors for thrombosis after liver transplantation: A genome-wide association study

DONOR-RECIPIENT GENETIC MISMATCH IS ASSOCIATED WITH LIVER ALLOGRAFT REJECTION

Exome sequencing in patient-parent trios suggests new candidate genes for early-onset primary sclerosing cholangitis

Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes

Read more